文献速递食管胃疾病与幽门螺杆菌消化道肿瘤与早癌

胃急性药物损伤与慢性炎症所致化生SPEM的单细胞转录分析

Single-cell transcriptional analyses of spasmolytic polypeptide-expressing metaplasia arising from acute drug injury and chronic inflammation in the stomach.
PubMed 文献 · Gut · 2019-09-03

该研究对健康胃、药物诱导及炎症诱导的SPEM(解痉多肽表达化生)胃体组织进行单细胞RNA测序,比较上皮细胞转录组。发现健康组织存在Muc6+Gif+细胞但不表达SPEM相关转录本;药物损伤与慢性炎症诱导的SPEM程序几乎一致,但免疫调节转录本仅在慢性炎症SPEM中独特诱导。结论提出SPEM定义需扩展至Tff2+Muc6+且不表达Gif的细胞,且SPEM为病因非依赖的高度保守程序,慢性炎症下获得免疫调节能力。

要点

  • SPEM定义应扩展至Tff2+Muc6+且不表达成熟主细胞转录本Gif的细胞。
  • 药物损伤与慢性炎症诱导的SPEM转录程序几乎一致,病因非依赖。
  • 免疫调节相关转录本仅在慢性炎症背景的SPEM细胞中独特诱导。

核心结论

  • SPEM由高度保守的细胞程序产生且不依赖病因,慢性炎症下发展出免疫调节能力。
  • SPEM定义需扩展至Tff2+Muc6+且不表达Gif等成熟主细胞转录本的细胞。

研究设计与样本

  • 从健康胃、药物诱导及炎症诱导SPEM胃体分离上皮细胞行单细胞RNA测序并比较转录组。

主要发现

  • 健康组织存在Muc6+Gif+细胞,但不表达SPEM相关转录本。
  • 药物损伤与慢性炎症的SPEM及颈细胞增生/肥大在SPEM相关转录本表达上几乎相同。
  • 免疫调节相关转录本诱导仅见于慢性炎症背景的SPEM细胞。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Spasmolytic polypeptide-expressing metaplasia (SPEM) is a regenerative lesion in the gastric mucosa and is a potential precursor to intestinal metaplasia/gastric adenocarcinoma in a chronic inflammatory setting. The goal of these studies was to define the transcriptional changes associated with SPEM at the individual cell level in response to acute drug injury and chronic inflammatory damage in the gastric mucosa. DESIGN: Epithelial cells were isolated from the gastric corpus of healthy stomachs and stomachs with drug-induced and inflammation-induced SPEM lesions. Single cell RNA sequencing (scRNA-seq) was performed on tissue samples from each of these settings. The transcriptomes of individual epithelial cells from healthy, acutely damaged and chronically inflamed stomachs were analysed and compared. RESULTS: scRNA-seq revealed a population Mucin 6 (Muc6)+gastric intrinsic factor (Gif)+ cells in healthy tissue, but these cells did not express transcripts associated with SPEM. Furthermore, analyses of SPEM cells from drug injured and chronically inflamed corpus yielded two major findings: (1) SPEM and neck cell hyperplasia/hypertrophy are nearly identical in the expression of SPEM-associated transcripts and (2) SPEM programmes induced by drug-mediated parietal cell ablation and chronic inflammation are nearly identical, although the induction of transcripts involved in immunomodulation was unique to SPEM cells in the chronic inflammatory setting. CONCLUSIONS: These data necessitate an expansion of the definition of SPEM to include Tff2+Muc6+ cells that do not express mature chief cell transcripts such as Gif. Our data demonstrate that SPEM arises by a highly conserved cellular programme independent of aetiology and develops immunoregulatory capabilities in a setting of chronic inflammation.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Bockerstett KA, Lewis SA, Wolf KJ, et al. Single-cell transcriptional analyses of spasmolytic polypeptide-expressing metaplasia arising from acute drug injury and chronic inflammation in the stomach. Gut. 2019. PMID: 31481545. doi:10.1136/gutjnl-2019-318930

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。